BCL2 and neoplasm: APG-2575 rapidly penetrates tumor cells and disrupts the Bcl-2–Bim complex, ultimately inducing Bax/Bak-dependent, caspase-mediated apoptosis, and demonstrating potent antitumor activity (Deng et al., 2022).